GL1X · GenesisL1 explorer

UniProt O75116

Rho-associated protein kinase 2 (O75116)

Rho-associated protein kinase 2 (UniProt O75116), EC 2.7.11.1: 22 experimental structures and 1 predicted model on GenesisL1, 14 ligands bound, 146 pockets. Binding sites, druggability and experiment against prediction (TM-score)…

UniProt
O75116
Protein
Rho-associated protein kinase 2
EC
2.7.11.1
Experimental structures
22
Predicted models
1
Ligands
14
Pockets
146 · 11 records with a druggable one

Structures

23 records of O75116 in the MolNFT archive: 22 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
4L6QROCK2 in complex with benzoxaborolex-ray diffractionA, B——
4L6QROCK2 in complex with benzoxaborolex-ray diffractionA, B——
4WOTROCK2 in complex with 1426382-07-1x-ray diffractionA, B, C, D——
5U7QIdentification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model…x-ray diffractionA, B, C, D—20 (best 0.79)
5U7QIdentification of a new class of potent CDC7 inhibitors designed by putative pharmacophore model…x-ray diffractionA, B, C, D——
5U7RIdentification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model…x-ray diffractionA, B, C, D81G20 (best 0.86)
5U7RIdentification of a new class of potent CDC7 inhibitors designed by putative pharmacophore model…x-ray diffractionA, B, C, D81G—
6ED6Crystal structure of Rock2 with a pyridinylbenzamide based inhibitorx-ray diffractionA, BJ0P9 (best 0.72)
6ED6Crystal structure of ROCK2 with a pyridinylbenzamide based inhibitorx-ray diffractionA, BJ0P—
6P5MDiscovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidi -Based Cdc7 inhibitor with…x-ray diffractionA, B, C, DO1S20 (best 0.87)
6P5MDiscovery of a novel, highly potent, and selective THIENO[3,2- D]PYRIMIDINONE-based CDC7 inhibitor…x-ray diffractionA, B, C, DO1S—
6P5PDiscovery of a novel, highly potent, and selective THIENO[3,2- D]PYRIMIDINONE-based CDC7 inhibitor…x-ray diffractionA, B, C, DO1V—
7JNTCrystal structure of rho-associated protein kinase 2 (ROCK2) in complex with a potent and selective…x-ray diffractionA, B, C, D, E, F, G, HVFA, CL20 (best 0.82)
7JNTCrystal structure of rho-associated protein kinase 2 (ROCK2) in complex with a potent and selective…x-ray diffractionA, B, C, D, E, F, G, HVFA, CL—
7JOVCrystal structure of rho-associated protein kinase 2 (ROCK2) in complex with a phenylpyrazole amide…x-ray diffractionA, B, C, D, E, F, G, HVFS, CL—
7JOVCrystal structure of rho-associated protein kinase 2 (ROCK2) in complex with a phenylpyrazole amide…x-ray diffractionA, B, C, D, E, F, G, HVFS, CL—
7P6NROCK2 in complex with compound 12x-ray diffractionA, B, C, D, E, F, G, H5YS—
8GDSCrystal structure of rho-associated protein kinase 2 (ROCK2) in complex with…x-ray diffractionA, B, C, DZ8O, SO420 (best 0.75)
8X8XCrystal structure of ROCK2 with GNS-2591 inhibitorx-ray diffractionA, BYDW, SO48 (best 0.71)
8X8YCrystal structure of ROCK2 with GNS-2660 inhibitorx-ray diffractionA, BYEA5 (best 0.70)
8X8ZCrystal structure of ROCK2 with GNS-2664 inhibitorx-ray diffractionA, BYEI, SO46 (best 0.71)
8X92Crystal structure of ROCK2 with GNS-2666 inhibitorx-ray diffractionA, BYEW, SO47 (best 0.71)
O75116AlphaFold monomer V2.0 prediction for rho-associated protein kinase 2 (O75116)predictedA—11 (best 0.66)

Ligands

  • CL · Chloride ion · in 4 records
  • SO4 · Sulfate ion · in 4 records
  • 81G · (1s,4s)-4-(4-fluorophenyl)-4-hydroxy-6'-(5-methyl-1H-pyrazol-4-yl)-1'H-spiro[cyclohexane-1,2'-thieno[3,2-d]pyrimidin]-4'(3'H)-one · in 2 records
  • J0P · N-[(2,3-dihydro-1,4-benzodioxin-5-yl)methyl]-4-(pyridin-4-yl)benzamide · in 2 records
  • O1S · 6-(5-methyl-1H-pyrazol-4-yl)-2-[(pyrrolidin-1-yl) methyl]thieno[3,2-d]pyrimidin-4(3H)-one · in 2 records
  • VFA · N-[(3-methoxyphenyl)methyl]-5H-[1]benzopyrano[3,4-c]pyridine-8-carboxamide · in 2 records
  • VFS · N-[(1S)-2-hydroxy-1-phenylethyl]-3-methoxy-4-(1H-pyrazol-4-yl)benzamide · in 2 records
  • 5YS · ~{N}-[(1~{R})-1-(3-methoxyphenyl)ethyl]-4-pyridin-4-yl-piperidine-1-carboxamide · in 1 record
  • O1V · 2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one · in 1 record
  • YDW · ~{N}-methyl-3-[[1-oxidanylidene-6-[5-(trifluoromethyl)-1~{H}-pyrazol-4-yl]isoquinolin-2-yl]methyl]benzamide · in 1 record
  • YEA · 3-fluoranyl-~{N}-methyl-5-[[1-oxidanylidene-6-[5-(trifluoromethyl)-1~{H}-pyrazol-4-yl]isoquinolin-2-yl]methyl]benzamide · in 1 record
  • YEI · ~{N}-methyl-3-[[6-(3-methyl-1,2-oxazol-4-yl)-1-oxidanylidene-isoquinolin-2-yl]methyl]benzamide · in 1 record
  • YEW · ~{N}-methyl-3-[[6-(2-methylpyrazol-3-yl)-1-oxidanylidene-isoquinolin-2-yl]methyl]benzamide · in 1 record
  • Z8O · 4-{4-[2-(2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]phenyl}phthalazin-1(2H)-one · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.